Amgen Inc SEC filings AMGN
Amgen Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 3 | Initial insider ownership | Oct 27, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2026 | Oct 26, 2026 |
| 3 | Initial insider ownership | Sep 4, 2026 | Sep 1, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| 4 | Insider transaction | Aug 12, 2026 | Aug 7, 2026 |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 4 | Insider transaction | Aug 10, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 10, 2026 | Aug 7, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 7, 2026 | Aug 6, 2026 |
| 144 | Notice of proposed sale | Aug 6, 2026 | — |
| 144/A | Filing | Aug 6, 2026 | — |
| 144 | Notice of proposed sale | Aug 6, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K | Current report | Jul 31, 2026 | Jul 29, 2026 |
| 11-K | Employee savings plan report | Jun 11, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 11, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 4 | Insider transaction | May 21, 2026 | May 19, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 20, 2026 | May 19, 2026 |
| 8-K |
Current report
Officer or director change
|
May 19, 2026 | May 19, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 14, 2026 | — |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 11, 2026 | May 7, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 5, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 4 | Insider transaction | May 5, 2026 | May 2, 2026 |
| 144 | Notice of proposed sale | May 4, 2026 | — |
| 10-Q | Quarterly report | May 1, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 30, 2026 | Apr 30, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Apr 22, 2026 | Apr 22, 2026 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| DEFA14A | Additional proxy material | Apr 7, 2026 | — |
| DEF 14A | Proxy statement | Apr 7, 2026 | May 19, 2026 |
| ARS | Annual report to shareholders | Mar 31, 2026 | Dec 31, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 16, 2026 |
| 4 | Insider transaction | Mar 6, 2026 | Mar 4, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 5, 2026 | Mar 3, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 144 | Notice of proposed sale | Feb 27, 2026 | — |
| 25-NSE | Delisting notice | Feb 24, 2026 | — |
| 4 | Insider transaction | Feb 20, 2026 | Feb 19, 2026 |
| 8-K |
Current report
Material agreement
|
Feb 19, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 19, 2026 | — |
| 424B2 | Prospectus | Feb 19, 2026 | — |
| FWP | Free writing prospectus | Feb 17, 2026 | — |
| 424B3 | Prospectus | Feb 17, 2026 | — |
| S-3ASR | Automatic shelf registration | Feb 13, 2026 | — |
| 10-K | Annual report | Feb 13, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 10, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Results of operations
|
Feb 3, 2026 | Feb 3, 2026 |
| 8-K |
Current report
Agreement ended
|
Jan 30, 2026 | Jan 30, 2026 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 20, 2025 |
| 144 | Notice of proposed sale | Nov 20, 2025 | — |
| 4 | Insider transaction | Nov 13, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 13, 2025 | Nov 12, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 11, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 7, 2025 |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 144 | Notice of proposed sale | Nov 12, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Nov 7, 2025 | Nov 5, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2025 | Nov 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Sep 8, 2025 | — |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 144 | Notice of proposed sale | Aug 20, 2025 | — |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 4 | Insider transaction | Aug 12, 2025 | Aug 8, 2025 |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 11-K | Employee savings plan report | Jun 12, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 12, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 144 | Notice of proposed sale | Jun 5, 2025 | — |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 28, 2025 | May 23, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 27, 2025 | May 23, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 8, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 6, 2025 | May 2, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 4 | Insider transaction | May 2, 2025 | Apr 30, 2025 |
| 144 | Notice of proposed sale | May 2, 2025 | — |
| 10-Q | Quarterly report | May 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 1, 2025 | May 1, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEFA14A | Additional proxy material | Apr 17, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 17, 2025 | — |
| PX14A6G | Filing | Apr 16, 2025 | — |
| DEFA14A | Additional proxy material | Apr 9, 2025 | — |
| DEF 14A | Proxy statement | Apr 9, 2025 | May 23, 2025 |
| ARS | Annual report to shareholders | Apr 2, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 19, 2025 | Mar 17, 2025 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AMGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Thousand Oaks, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 318154
Other Biological Products, (No Diagnostic Substances) companies
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.